AS1411-targeted nanomedicines for precision cancer therapy: Advances, mechanisms, and translational perspectives.
Conventional cancer chemotherapy is frequently compromised by nonspecific biodistribution, dose-limiting systemic toxicity, inadequate tumor accumulation, and multidrug resistance, highlighting the need for targeted nanomedicines capable of improving tumor selectivity while preserving therapeutic efficacy. The AS1411 G...